The Enterprise Value as of September 2024 (TTM) for Arcutis Biotherapeutics, Inc. (ARQT) is 1.33B

According to Arcutis Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.33B. This represents a change of 64.90% compared to the average of 808.78M of the last 4 quarters.

Arcutis Biotherapeutics, Inc. (ARQT) Historical Enterprise Value (quarterly & annually)

How has ARQT Enterprise Value performed in the past?

The mean historical Enterprise Value of Arcutis Biotherapeutics, Inc. over the last ten years is 680.66M. The current 1.33B Enterprise Value has changed 19.49% with respect to the historical average. Over the past ten years (40 quarters), ARQT's Enterprise Value was at its highest in in the June 2024 quarter at 1.30B. The Enterprise Value was at its lowest in in the June 2018 quarter at 0.

Arcutis Biotherapeutics, Inc. (ARQT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Arcutis Biotherapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arcutis Biotherapeutics, Inc. (ARQT) Average Enterprise Value

How has ARQT Enterprise Value performed in the past?

The current Enterprise Value of Arcutis Biotherapeutics, Inc. (ARQT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Arcutis Biotherapeutics, Inc. (ARQT) Enterprise Value vs. Peers

How is ARQT’s Enterprise Value compared to its peers?

Arcutis Biotherapeutics, Inc.’s Enterprise Value is greater than Terns Pharmaceuticals, Inc. (458.36M), greater than Amylyx Pharmaceuticals, Inc. (89.50M), greater than Acumen Pharmaceuticals, Inc. (93.64M), greater than Inozyme Pharma, Inc. (343.89M), greater than X4 Pharmaceuticals, Inc. (40.79M), greater than Icosavax, Inc. (713.87M), less than Mirum Pharmaceuticals, Inc. (2.05B), greater than VectivBio Holding AG (848.58M), greater than Day One Biopharmaceuticals, Inc. (1.01B), less than Mirati Therapeutics, Inc. (3.91B), less than Apellis Pharmaceuticals, Inc. (5.11B), greater than Spero Therapeutics, Inc. (12.49M), greater than Bolt Biotherapeutics, Inc. (37.47M), greater than Coherus BioSciences, Inc. (281.96M), less than Gracell Biotechnologies Inc. (5.45B), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than Theseus Pharmaceuticals, Inc. (138.26M), greater than Monte Rosa Therapeutics, Inc. (284.72M), greater than Design Therapeutics, Inc. (221.42M), greater than Erasca, Inc. (689.13M),

Build a custom stock screener for Arcutis Biotherapeutics, Inc. (ARQT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arcutis Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arcutis Biotherapeutics, Inc. (ARQT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arcutis Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.